Prevention of risks from occupational exposure to antineoplastic drugs. Consensus document. 1996

L Alessio, and P Apostoli, and F Draicchio, and A Forni, and R Lucchini, and E Merler, and S Palazzo, and R Scarselli, and D Sossai
Cattedra di Medicina del Lavoro, Università degli Studi di Brescia.

UI MeSH Term Description Entries
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012449 Safety Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property. Safeties
D016273 Occupational Exposure The exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one's occupation. Exposure, Occupational,Exposures, Occupational,Occupational Exposures
D017408 Guidelines as Topic Works about a systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels. For guidelines in the field of health care and clinical medicine, PRACTICE GUIDELINES AS TOPIC is available. Guidelines as Topics

Related Publications

L Alessio, and P Apostoli, and F Draicchio, and A Forni, and R Lucchini, and E Merler, and S Palazzo, and R Scarselli, and D Sossai
September 2005, Sangyo eiseigaku zasshi = Journal of occupational health,
L Alessio, and P Apostoli, and F Draicchio, and A Forni, and R Lucchini, and E Merler, and S Palazzo, and R Scarselli, and D Sossai
January 1987, Archiv fur Geschwulstforschung,
L Alessio, and P Apostoli, and F Draicchio, and A Forni, and R Lucchini, and E Merler, and S Palazzo, and R Scarselli, and D Sossai
January 2020, Toxicological research,
L Alessio, and P Apostoli, and F Draicchio, and A Forni, and R Lucchini, and E Merler, and S Palazzo, and R Scarselli, and D Sossai
May 1993, Lancet (London, England),
L Alessio, and P Apostoli, and F Draicchio, and A Forni, and R Lucchini, and E Merler, and S Palazzo, and R Scarselli, and D Sossai
August 1998, Mutation research,
L Alessio, and P Apostoli, and F Draicchio, and A Forni, and R Lucchini, and E Merler, and S Palazzo, and R Scarselli, and D Sossai
September 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners,
L Alessio, and P Apostoli, and F Draicchio, and A Forni, and R Lucchini, and E Merler, and S Palazzo, and R Scarselli, and D Sossai
January 2004, Soins; la revue de reference infirmiere,
L Alessio, and P Apostoli, and F Draicchio, and A Forni, and R Lucchini, and E Merler, and S Palazzo, and R Scarselli, and D Sossai
October 2007, ONS connect,
L Alessio, and P Apostoli, and F Draicchio, and A Forni, and R Lucchini, and E Merler, and S Palazzo, and R Scarselli, and D Sossai
November 2021, International archives of occupational and environmental health,
L Alessio, and P Apostoli, and F Draicchio, and A Forni, and R Lucchini, and E Merler, and S Palazzo, and R Scarselli, and D Sossai
November 2014, Nutricion hospitalaria,
Copied contents to your clipboard!